HEADER ANTIBIOTIC 05-MAY-06 2GWP TITLE HIGH-RESOLUTION SOLUTION STRUCTURE OF THE SALT-BRIDGE DEFFICIENT MOUSE TITLE 2 DEFENSIN (E15D)-CRYPTDIN4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: DEFENSIN-RELATED CRYPTDIN 4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CRYPTDIN4; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: DEFCR4; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)-CODON-PLUS-RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET-28A KEYWDS TRIPLE STRANDED BETA SHEET, BETA HAIRPIN, ANTIBIOTIC EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR K.J.ROSENGREN,D.J.CRAIK,H.J.VOGEL,N.L.DALY,A.J.OUELLETTE REVDAT 4 20-OCT-21 2GWP 1 REMARK SEQADV REVDAT 3 24-FEB-09 2GWP 1 VERSN REVDAT 2 10-OCT-06 2GWP 1 JRNL REVDAT 1 25-JUL-06 2GWP 0 JRNL AUTH K.J.ROSENGREN,N.L.DALY,L.M.FORNANDER,Y.SHIRAFUJI,X.QU, JRNL AUTH 2 H.J.VOGEL,A.J.OUELLETTE,D.J.CRAIK JRNL TITL STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF THE CONSERVED JRNL TITL 2 SALT BRIDGE IN MAMMALIAN PANETH CELL ALPHA-DEFENSINS: JRNL TITL 3 SOLUTION STRUCTURES OF MOUSE CRYPTDIN-4 AND JRNL TITL 4 (E15D)-CRYPTDIN-4. JRNL REF J.BIOL.CHEM. V. 281 28068 2006 JRNL REFN ISSN 0021-9258 JRNL PMID 16857681 JRNL DOI 10.1074/JBC.M604992200 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : XWINNMR 1.3.5, CNS 1.0 REMARK 3 AUTHORS : BRUKER (XWINNMR), BRUNGER, A.T. ET AL. (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GWP COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-MAY-06. REMARK 100 THE DEPOSITION ID IS D_1000037641. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 288; 293; 298; 303; 308 REMARK 210 PH : 5.1; 5.1; 5.1; 5.1; 5.1 REMARK 210 IONIC STRENGTH : 0; 0; 0; 0; 0 REMARK 210 PRESSURE : AMBIENT; AMBIENT; AMBIENT; REMARK 210 AMBIENT; AMBIENT REMARK 210 SAMPLE CONTENTS : 0.6 MG (E15D)-CRYPTDIN4 / 0.5ML; REMARK 210 90% H2O / 10% D2O; 0.6 MG (E15D)- REMARK 210 CRYPTDIN4 / 0.5ML; 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY; 2D TOCSY; DQF-COSY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CARA 1.0, CYANA 2.0 REMARK 210 METHOD USED : STRUCTURE WAS CALCULATED USING REMARK 210 TORSION ANGLE DYNAMICS FOLLOWED REMARK 210 BY REFINEMENT IN EXPLICIT REMARK 210 SOLVENT USING CARTESIAN DYNAMICS REMARK 210 WITHIN CNS. REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS,STRUCTURES REMARK 210 WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: THIS STRUCTURE WAS DETERMINED USING STANDARD 2D REMARK 210 HOMONUCLEAR TECHNIQUES. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 H3 GLY A 1 O ARG A 32 1.56 REMARK 500 HH TYR A 5 OD2 ASP A 15 1.58 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 HIS A 10 177.58 178.83 REMARK 500 1 ARG A 13 76.32 -69.83 REMARK 500 2 LEU A 2 -49.53 -177.73 REMARK 500 2 HIS A 10 -179.68 -177.17 REMARK 500 2 ILE A 23 85.39 -59.72 REMARK 500 2 ARG A 24 31.03 72.88 REMARK 500 3 LEU A 2 -52.60 -167.02 REMARK 500 3 HIS A 10 174.41 179.30 REMARK 500 3 ILE A 23 95.96 -57.89 REMARK 500 4 ASP A 15 -168.92 -78.61 REMARK 500 4 ILE A 23 85.35 -60.55 REMARK 500 4 ARG A 31 35.86 -87.51 REMARK 500 5 ILE A 23 96.26 -61.54 REMARK 500 6 LEU A 3 45.47 -158.19 REMARK 500 6 ARG A 13 107.26 -52.82 REMARK 500 6 ILE A 23 93.93 -62.12 REMARK 500 7 ILE A 23 91.91 -61.62 REMARK 500 8 LEU A 2 -122.43 -79.68 REMARK 500 8 HIS A 10 161.32 179.93 REMARK 500 9 LEU A 3 45.36 -151.88 REMARK 500 9 ARG A 13 101.56 -59.03 REMARK 500 9 ILE A 23 91.32 -53.30 REMARK 500 10 HIS A 10 170.74 179.84 REMARK 500 10 ILE A 23 95.82 -61.20 REMARK 500 10 ARG A 31 -61.82 -103.77 REMARK 500 11 ARG A 13 105.82 -55.94 REMARK 500 11 ILE A 23 88.91 -61.32 REMARK 500 12 ILE A 23 91.41 -62.26 REMARK 500 13 LEU A 3 38.48 -147.76 REMARK 500 13 CYS A 21 -49.58 -147.17 REMARK 500 13 ILE A 23 93.81 -62.32 REMARK 500 13 ARG A 24 34.13 71.58 REMARK 500 13 ARG A 31 -31.70 -170.16 REMARK 500 14 HIS A 10 174.44 179.11 REMARK 500 14 ARG A 13 83.46 -67.93 REMARK 500 14 ILE A 23 93.44 -60.57 REMARK 500 14 ARG A 31 -33.91 -134.50 REMARK 500 15 HIS A 10 -179.61 -179.87 REMARK 500 15 ARG A 13 98.69 -59.97 REMARK 500 15 ASP A 15 -165.01 -73.40 REMARK 500 15 ILE A 23 93.42 -60.43 REMARK 500 16 ARG A 13 96.09 -61.08 REMARK 500 16 ILE A 23 97.96 -63.24 REMARK 500 16 ARG A 31 -72.96 -59.45 REMARK 500 17 ARG A 13 90.56 -64.43 REMARK 500 17 ILE A 23 97.31 -60.90 REMARK 500 17 ARG A 24 33.21 71.48 REMARK 500 18 ARG A 13 79.86 -67.33 REMARK 500 18 ILE A 23 97.78 -55.51 REMARK 500 19 HIS A 10 164.47 179.30 REMARK 500 REMARK 500 THIS ENTRY HAS 55 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2GW9 RELATED DB: PDB REMARK 900 STRUCTURE OF THE NATIVE CRYPTDIN4 PEPTIDE DBREF 2GWP A 1 32 UNP P28311 DEF4_MOUSE 61 92 SEQADV 2GWP ASP A 15 UNP P28311 GLU 75 ENGINEERED MUTATION SEQRES 1 A 32 GLY LEU LEU CYS TYR CYS ARG LYS GLY HIS CYS LYS ARG SEQRES 2 A 32 GLY ASP ARG VAL ARG GLY THR CYS GLY ILE ARG PHE LEU SEQRES 3 A 32 TYR CYS CYS PRO ARG ARG SHEET 1 A 3 TYR A 5 LYS A 8 0 SHEET 2 A 3 PHE A 25 CYS A 29 -1 O LEU A 26 N ARG A 7 SHEET 3 A 3 ARG A 16 GLY A 22 -1 N ARG A 18 O TYR A 27 SSBOND 1 CYS A 4 CYS A 29 1555 1555 2.03 SSBOND 2 CYS A 6 CYS A 21 1555 1555 2.03 SSBOND 3 CYS A 11 CYS A 28 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1